We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The University at Buffalo (UB) has signed an agreement with Sleep Solutions,
the medical device and healthcare services company providing direct-to-patient
testing services, to commercialize and distribute an innovative diagnostic testing
technology for Obstructive Sleep Apnea and Cheyne-Stokes Respiration.
QTL Biosystems announced the introduction of its Universal Development Kit for
Kinase and Phosphatase Assays following the release of additional Serine/Threonine
and Tyrosine Kinases.
Advanced Research Technologies (ART) has obtained authorization from Health
Canada's Therapeutic Products Directorate to begin its pivotal clinical study
in Canada for its SoftScan optical breast imaging system.
Biophan Technologies, a developer of next-generation biomedical technology,
has been issued Patent No. 6,864,418, "Nanomagnetically Shielded Substrate,"
by the U.S. Patent and Trademark Office.
The Centers for Medicare & Medicaid Services (CMS) issued a final decision
that would immediately expand coverage of carotid artery stenting for high-risk
patients with symptomatic narrowing of carotid artery of 70 percent or more.
Beckman Coulter introduced Cell Lab Quanta, a new flow cytometry solution for
affordable cellular analysis in research and drug discovery applications.
Medical Home Products, a provider of medical self test kits and diabetics supplies,
announced that the company has issued a letter of intent (LOI) to acquire an
established diabetic supply company.